基础医学与临床 ›› 2010, Vol. 30 ›› Issue (1): 19-23.

• 研究论文 • 上一篇    下一篇

同种异基因骨髓腔内骨髓移植促进小鼠早期造血功能重建

袁雅红 王泳 翁震 丁妍 李东升   

  1. 郧阳医学院附属太和医院 郧阳医学院附属太和医院
  • 收稿日期:2009-04-08 修回日期:2009-06-12 出版日期:2010-01-05 发布日期:2010-01-05
  • 通讯作者: 李东升

Effects of Allogenic Intra-bone Marrow Bone Marrow Transplantation on the Hematopoiesis in Mice

Ya-hong YUAN, Yong WANG, Zhen WENG, Yan DING, Dong-sheng LI   

  1. Taihe Hospital, Yunyang Medical College Taihe Hospital, Yunyang Medical College
  • Received:2009-04-08 Revised:2009-06-12 Online:2010-01-05 Published:2010-01-05
  • Contact: Dong-sheng LI

摘要: 目的 探讨同种异基因骨髓腔内骨髓移植(IBM-BMT) 对小鼠早期造血功能重建的影响。方法 将BALB/c小鼠骨髓单个核细胞(BMNCs)分别用胫骨骨髓腔内注射(IBMI)和尾静脉注射(IV)两种方法移植入经致死量60Coγ射线辐照后的60只C57BL/6小鼠。受鼠随机分为3组:骨髓腔内注射高和低剂量组(IBM1和IBM2组)、尾静脉注射组(IV组),每组20只。在骨髓移植后1、3、6 和9 d 分别计数各组受鼠胫骨骨髓腔内有核细胞总数,并用流式细胞术检测供体植入水平(供体来源有核细胞总数、供体来源髓系细胞数)。结果 于移植后6 d,IBM1 组和IBM2 组注射侧胫骨骨髓腔内有核细胞总数、供体来源有核细胞总数、供体来源髓系细胞总数均明显高于IV组﹙P<0.05或P<0.01﹚。结论 IBM-BMT 较IV-BMT 更能促进同种异基因骨髓移植后的早期造血功能重建。

关键词: 骨髓腔内注射, 尾静脉注射, 造血恢复, 异基因骨髓移植

Abstract: Objective To investigate the effects of allogenic intra-bone marrow bone marrow transplantation ( IBM-BMT) on re-establishing hematopoiesis in mice. Methods Bone marrow mononuclear cells (BMNCs) from BALB/c mice were transplanted into the C57BL/6 mice treated with a lethal dose of 60Coγ-ray radiation either by intra-bone marrow injection or intravenous injection. Sixty of the C57BL/6 mice were randomly divided into three groups as higher dose intra-bone marrow injection group (IBM1 group), lower dose intra-bone marrow injection group (IBM2 group) and intravenous injection group (IV group) with 20 in each group. The nucleated cell numbers of whole bone marrow from the tibia of each recipient mouse were counted respectively at the day 1, day 3, day 6 and day 9 after the transplantation. The numbers of donor-derived total nucleated cells and myeloid cells were further analyzed by flow cytometry. Results At 6th day after transplantation, the numbers of total bone marrow nucleated cells, total donor-derived nucleated cells and donor-derived myeloid cells in the tibia of injected side in both IBM1 group and IBM2 group were all significantly higher than those in IV group (P<0.05 or P<0.01). Conclusion Compared with traditional bone marrow transplantation (IV-BMT), IBM-BMT improves the bone marrow hematopoiesis in the early hematopoietic re-establishing stage in allogenic bone marrow transplantation.

Key words: intra-bone marrow injection, tail intravenous injection, hematopoietic recovery, allogenic bone marrow transplantation